Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of veverimer for treating metabolic acidosis in chronic kidney disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Metabolic Acidosis

Drugs mentioned

• Veverimer

Snippet

Sponsor: Renibus Therapeutics, Inc. | Conditions: CKD, Metabolic Acidosis | Phase 3 | Status: RECRUITING